ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
13 announcements with these filters
Poly Medicure conducted its 31st Annual General Meeting on September 5, 2026, via video conferencing. This filing provides a summary of the meeting's proceedings and agenda items.
Poly Medicure has filed its Notice of the 31st Annual General Meeting and the Annual Report for the financial year ended March 31, 2026.
Poly Medicure has announced a record date of August 29, 2026, for a final dividend of ₹3.50 per equity share for FY 2025-26.
Poly Medicure Limited has scheduled its 31st Annual General Meeting for September 05, 2026, to transact ordinary and special businesses, including dividend declaration.
PolyMed Q1FY27 shows strong standalone margin performance beating guidance, but consolidated numbers are dragged by the Middle East crisis and pricing pressure in the renal segment from Chinese dumping.
Poly Medicure Limited allotted equity shares under its Employee Stock Option Plan (ESOP). This issuance increases the company's paid-up share capital.
Poly Medicure Limited has re-appointed M/s. Jai Prakash & Company as Cost Auditors for the company.
Poly Medicure Limited announced the resignation of Mr. Ravi Prakash from his position as Deputy Company Secretary, effective August 10, 2026.
Poly Medicure reported strong Q1 FY27 consolidated revenue growth of 30.3% YoY, driven by acquisitions (Citieffe, PendraCare) and domestic expansion. Strategy shifts towards high-complexity medical devices like Cardiology and Orthopaedics.
Poly Medicure Ltd reported revenue from operations of ₹525.4 Cr (+30.3% YoY) and net profit of ₹85.3 Cr (-8.4% YoY) for Q1 FY27.
Poly Medicure Limited has scheduled a Board Meeting on August 7, 2026, to consider and approve the unaudited financial results for the quarter ending June 30, 2026.
Poly Medicure Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended June 30, 2026. This is a routine periodic regulatory disclosure.
Poly Medicure disclosed that the Delhi High Court stayed the stamp duty order dated 15 June 2026. The case is ongoing and the company will update investors.